Security key
38942Q202
CalciMedica, Inc. - Common Stock, $0.0001 par value per share (CALC)
CUSIP: 38942Q202
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 591,636
- Total 13F value
- $1,561,335
- Share change
- -85,077
- SEC-reported price per share
- $2.66
- Number of holders
- 11
- Value change
- -$597,671
- Number of buys
- 6
- Number of sells
- 3
- Shares outstanding
- 30,511,392
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
11
Top holders
10
CALC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
CalciMedica, Inc. SEC filings
CalciMedica, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 38942Q202
Recent filing periods:
Ownership snapshot
Top reported holders of CALC - CalciMedica, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
Valence Investments SPV I...
Comparable rows
12/15
Latest evidence
30 Jun 2023
13F
3/4/5
Lead comparable stake: 0.97%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 0.97%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
0.97%
DEERFIELD MANAGEMENT COMPANY, L.P.
0.87%
BML Capital Management, LLC
0.29%
FIRST MANHATTAN CO. LLC.
0.04%
MERITAGE PORTFOLIO MANAGEMENT
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
0.97%
|
$1,192,494
297,380 shares
|
— | 30 Jun 2023 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
0.87%
|
$1,065,285
265,657 shares
|
— | 30 Jun 2023 |
| BML Capital Management, LLC |
13F
Company
|
0.29%
|
$356,012
88,781 shares
|
— | 30 Jun 2023 |
| FIRST MANHATTAN CO. LLC. |
13F
Company
|
0.04%
|
$53,036
13,226 shares
|
— | 30 Jun 2023 |
| MERITAGE PORTFOLIO MANAGEMENT |
13F
Company
|
0.03%
|
$40,000
10,000 shares
|
— | 30 Jun 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.01%
|
$7,547
1,882 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
591,636
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q4 2025 Across Filers
Q4 2025 holders
30
Q3 2023 holders
11
Holder diff
-19
| Investor | Q4 2025 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend